CrushSCI.com
108.9Average days
91Median days
40Fastest days
260Longest days
752025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

101 days

Sex-related differences in time-to-onset of immune checkpoint inhibitor-related interstitial lung disease: a JADER pharmacovigilance study

Authors
Naohito Ide; Minori Yamashita; Miyako Yamashita; Ryusuke Watanabe; Chika Moriya; Rin Yagome; Ken-ichi Sako; Tomoji MaedaShow moreShow less
Affiliations
1. Department of Clinical Pharmacology, Nihon Pharmaceutical UniversityShow moreShow less
Source PDF DOI Publisher page
46 days

Time-dependent indirect comparison of enfortumab vedotin plus pembrolizumab and disitamab vedotin plus toripalimab in advanced urothelial carcinoma

Authors
Hiroki Tanaka; Hiroshi Fukushima; Wei Chen; Fei Li; Soichiro Yoshida; Yasuhisa FujiiShow moreShow less
Affiliations
1. Department of Urology, Institute of Science Tokyo; 2. Department of Urology, Zigong Fourth People’s Hospital; 3. Department of Urology, Nanfang Hospital, Southern Medical UniversityShow moreShow less
Source PDF DOI Publisher page
41 days

Integrative topological and longitudinal transcriptomic analyses identify a 14-gene interferon-stimulated module associated with acquired sunitinib resistance in clear cell renal cell carcinoma

Authors
Wenhao Chu; Fuhao Wang; Liangkuan Bi; Xing FuShow moreShow less
Affiliations
1. Department of Urology, the First Affiliated Hospital of Anhui Medical University; 2. Department of Urology, Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, and Shenzhen Clinical Research Center for Urology and Nephrology, Peking University Shenzhen Hospital; 3. School of Medicine, Southern University of Science and TechnologyShow moreShow less
Source PDF DOI Publisher page
75 days

Emerging roles of long non-coding RNA CASC2 in tumor chemoresistance – a review

Authors
Lingyun Zhou; Jintao He; Wenbing Huang; Zhengliang Li; Min Yu; Jiangyan Li; Wenzhong Yang; Wei XiongShow moreShow less
Affiliations
1. Department of Biochemistry and Molecular Biology, Health Science Center, College of Basic Medical Sciences, Dali University; 2. Key Laboratory of Clinical Biochemistry Testing in Universities of Yunnan Province, Health Science Center, School of Basic Medical Sciences, Dali University; 3. Department of Radiology, The First Affiliated Hospital of Dali University, Dali University; 4. Department of Biochemistry and Molecular Biology, College of Life Sciences, Yunnan University; 5. Department of Surgery, Health Science Center, College of Clinical Medicine, Dali UniversityShow moreShow less
Source PDF DOI Publisher page
57 days

Hepatic arterial infusion chemotherapy plus lenvatinib with or without PD-1 inhibition for unresectable hepatocellular carcinoma: a retrospective cohort study

Authors
Haidong Yu; Cunkai Ma; Cairang Yangdan; Haiming Yang; Xiaolei XuShow moreShow less
Affiliations
1. Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qinghai University; 2. Department of Interventional Therapy, The Affiliated Hospital of Qinghai UniversityShow moreShow less
Source PDF DOI Publisher page
77 days

Longitudinal acquisition and infection risk associated with multidrug-resistant organisms and Candida colonization in intensive care unit patients

Authors
Ülkü Altoparlak; Hatice Erdoğan; Mine Çelik; Gülden AksuShow moreShow less
Affiliations
1. Department of Medical Microbiology, Haseki Training and Research Hospital; 2. Department of Anesthesiology and Reanimation, Haseki Training and Research HospitalShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF CHEMOTHERAPY take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for JOURNAL OF CHEMOTHERAPY. The fastest paper went from submission to acceptance in 40 days (Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia, received 2025-07-18, accepted 2025-08-27); the slowest took 260 days. The average is 108.9 days and the median is 91 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.